Antrinkos Andrew Aristidou

age:

56 years

appointments:

25 active

23 prior

primary industry:

Financial service activities, except insurance and pension funding

about Antrinkos

Since 2019, Aristidou has been a director of 48 companies, the current directorship have a combined turnover of approximately £7.5b.

Combined Valuation

£132.5b

Combined Turnover

£7.5b

active directorships over time

company
turnover
valuation
start
end
status
role
haleon uk services limited£906.6m£40.2bAug 2019-OpenDirector
consumer healthcare holdings limited-£35bSep 2019-OpenDirector
haleon uk enterprises limited-£25.2bSep 2019-OpenDirector
consumer healthcare intermediate holdings limited-£14bSep 2019-OpenDirector
haleon uk ip limited£187.9m£3.5bAug 2019-OpenDirector
kyowa kirin international plc-£3.4bDec 2020-OpenDirector
haleon uk trading services limited£4.6b£2.9bAug 2019-OpenDirector
kyowa kirin services ltd£346.8m£2.5bSep 2020-OpenDirector
haleon uk trading limited£1.1b£2.2bAug 2019-OpenDirector
haleon uk finance limited-£1.2bAug 2019-OpenDirector
haleon uk holding canada limited-£1.2bDec 2019-OpenDirector
haleon uk ip (no. 2) limited£2.2m£404.5mAug 2019-OpenDirector
kyowa kirin international holdco ltd£18.7m£363.1mNov 2022-OpenDirector
haleon uk export limited£274.5m£334.5mMar 2020-OpenDirector
kyowa kirin limited£50m£53.5mSep 2020-OpenDirector
haleon uk holding sri lanka limited-£47.4mAug 2019-OpenDirector
haleon uk research limited£1.1m£37.5mAug 2019-OpenDirector
glaxosmithkline consumer healthcare (uk) (no.1) limited-£23.6mAug 2019-OpenDirector
haleon uk holding new zealand limited-£13.7mDec 2019-OpenDirector
kyowa kirin pharmaceutical development limited£7m£10.7mSep 2020-OpenDirector
kki grunenthal uk holdco ltd--Nov 2022-OpenDirector
archimedes pharma uk limited--Sep 2023-OpenDirector
glaxosmithkline consumer healthcare investments (ireland) (no.2) unlimited company£23.6m-Aug 2019-OpenDirector
glaxosmithkline consumer healthcare investments (ireland) (no 3) limited--Aug 2019-OpenDirector